Skip to main content Skip to main content
Go to homepage
Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

New Medication for Duchenne Muscular Dystrophy

Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

Description:

For complete information, please visit the study on Clinicaltrials.gov

Interested in participating?
We are currently recruiting
Study Sponsor:

Capricor, Inc.

Full IRB Study Title:
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
IRB Study ID:
2022-177
If you are interested in this study or have questions about your child's eligibility, please contact:

Hilary Tonni, RN
330-543-4734
htonni@akronchildrens.org

Lead Investigator
Kathryn Mosher, MD

Pediatric Physiatrist; Director, Neuromuscular Clinic
NeuroDevelopmental Science CenterPhysical Medicine and RehabilitationPediatric Neuromuscular ClinicPediatric Brain Tumor ProgramPediatric Spasticity ClinicInpatient Rehabilitation ProgramDay Rehabilitation Program

Starting Locations:
Career Opportunities
Legal:
Mobile App:

Akron Children's Anywhere:

About Akron Children's

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...

Akron Children's
One Perkins Square, Akron, Ohio 44308-1062
330-543-1000 • webmaster@akronchildrens.org
An Equal Opportunity Employer
Copyright © 2020, Akron Children's. All Rights Reserved.
  • Magnet Recongnition
  • Newsweek: World's Best Hospitals - 2023
  • Newsweek: World's Best Hospitals - Pediatrics 2023

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.